Home/Axim Biotech/Dr. Timothy R. Scott

DT

Dr. Timothy R. Scott

Board Director

Therapeutic Areas

Ophthalmology Oncology Cannabinoids

Axim Biotech Pipeline

Drug	Indication	Phase
TearScan Lf	Aqueous-Deficient Dry Eye Disease	Commercial
TearScan IgE	Allergic Conjunctivitis	Commercial
Quantitative Tear MMP-9 Test	Inflammatory Dry Eye Disease	Development
QSOX1-L Based Cancer Test	Early Cancer Detection	Prototype

Leadership Team at Axim Biotech

Catalina Valencia

Chief Executive Officer, President

Dr. Sergei A. Svarovsky

Chief Scientific Officer

Dr. Alan J. Touch

Chief Medical & Regulatory Affairs Advisor

View full Axim Biotech profile